Report of two cases of idiopathic membranousnephropathy with high antibody titer treated with plasma replacement combined with CD20 monoclonal antibody
<正>特发性膜性肾病（idiopathic membranous nephropathy,IMN）是原发性肾病综合征的主要病因,患病人数在我国呈逐年上升趋势[1]。根据2012年改善全球肾脏病预后组织（Kidney Disease:Improving Global Outcomes,KDIGO）[2]治疗指南,建议表现为肾病综合征的IMN患者有以下情况之一的考虑应用免疫抑制剂治疗:（1）经过至少6个月的降血压和降蛋白尿治疗,...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Nephrology
2020-01-01
|
| Series: | Linchuang shenzangbing zazhi |
| Subjects: | |
| Online Access: | http://www.lcszb.com/thesisDetails?columnId=57906645&Fpath=home&index=0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850143152605757440 |
|---|---|
| author | XU Tian WANG Yan-qiu LIU Ying TIAN Mi ZHOU Hua LI De-tian |
| author_facet | XU Tian WANG Yan-qiu LIU Ying TIAN Mi ZHOU Hua LI De-tian |
| author_sort | XU Tian |
| collection | DOAJ |
| description | <正>特发性膜性肾病（idiopathic membranous nephropathy,IMN）是原发性肾病综合征的主要病因,患病人数在我国呈逐年上升趋势[1]。根据2012年改善全球肾脏病预后组织（Kidney Disease:Improving Global Outcomes,KDIGO）[2]治疗指南,建议表现为肾病综合征的IMN患者有以下情况之一的考虑应用免疫抑制剂治疗:（1）经过至少6个月的降血压和降蛋白尿治疗, |
| format | Article |
| id | doaj-art-6dfdf95d596d4c67987a6c077b869a59 |
| institution | OA Journals |
| issn | 1671-2390 |
| language | zho |
| publishDate | 2020-01-01 |
| publisher | Editorial Department of Journal of Clinical Nephrology |
| record_format | Article |
| series | Linchuang shenzangbing zazhi |
| spelling | doaj-art-6dfdf95d596d4c67987a6c077b869a592025-08-20T02:28:49ZzhoEditorial Department of Journal of Clinical NephrologyLinchuang shenzangbing zazhi1671-23902020-01-011017102057906645Report of two cases of idiopathic membranousnephropathy with high antibody titer treated with plasma replacement combined with CD20 monoclonal antibodyXU TianWANG Yan-qiuLIU YingTIAN MiZHOU HuaLI De-tian<正>特发性膜性肾病（idiopathic membranous nephropathy,IMN）是原发性肾病综合征的主要病因,患病人数在我国呈逐年上升趋势[1]。根据2012年改善全球肾脏病预后组织（Kidney Disease:Improving Global Outcomes,KDIGO）[2]治疗指南,建议表现为肾病综合征的IMN患者有以下情况之一的考虑应用免疫抑制剂治疗:（1）经过至少6个月的降血压和降蛋白尿治疗,http://www.lcszb.com/thesisDetails?columnId=57906645&Fpath=home&index=0特发性膜性肾病磷脂酶A2受体（PLA2R）CD20单克隆抗体血浆置换 |
| spellingShingle | XU Tian WANG Yan-qiu LIU Ying TIAN Mi ZHOU Hua LI De-tian Report of two cases of idiopathic membranousnephropathy with high antibody titer treated with plasma replacement combined with CD20 monoclonal antibody Linchuang shenzangbing zazhi 特发性膜性肾病 磷脂酶A2受体（PLA2R） CD20单克隆抗体 血浆置换 |
| title | Report of two cases of idiopathic membranousnephropathy with high antibody titer treated with plasma replacement combined with CD20 monoclonal antibody |
| title_full | Report of two cases of idiopathic membranousnephropathy with high antibody titer treated with plasma replacement combined with CD20 monoclonal antibody |
| title_fullStr | Report of two cases of idiopathic membranousnephropathy with high antibody titer treated with plasma replacement combined with CD20 monoclonal antibody |
| title_full_unstemmed | Report of two cases of idiopathic membranousnephropathy with high antibody titer treated with plasma replacement combined with CD20 monoclonal antibody |
| title_short | Report of two cases of idiopathic membranousnephropathy with high antibody titer treated with plasma replacement combined with CD20 monoclonal antibody |
| title_sort | report of two cases of idiopathic membranousnephropathy with high antibody titer treated with plasma replacement combined with cd20 monoclonal antibody |
| topic | 特发性膜性肾病 磷脂酶A2受体（PLA2R） CD20单克隆抗体 血浆置换 |
| url | http://www.lcszb.com/thesisDetails?columnId=57906645&Fpath=home&index=0 |
| work_keys_str_mv | AT xutian reportoftwocasesofidiopathicmembranousnephropathywithhighantibodytitertreatedwithplasmareplacementcombinedwithcd20monoclonalantibody AT wangyanqiu reportoftwocasesofidiopathicmembranousnephropathywithhighantibodytitertreatedwithplasmareplacementcombinedwithcd20monoclonalantibody AT liuying reportoftwocasesofidiopathicmembranousnephropathywithhighantibodytitertreatedwithplasmareplacementcombinedwithcd20monoclonalantibody AT tianmi reportoftwocasesofidiopathicmembranousnephropathywithhighantibodytitertreatedwithplasmareplacementcombinedwithcd20monoclonalantibody AT zhouhua reportoftwocasesofidiopathicmembranousnephropathywithhighantibodytitertreatedwithplasmareplacementcombinedwithcd20monoclonalantibody AT lidetian reportoftwocasesofidiopathicmembranousnephropathywithhighantibodytitertreatedwithplasmareplacementcombinedwithcd20monoclonalantibody |